Biodexa Pharmaceuticals (LON:MTPH) Share Price Crosses Below 200-Day Moving Average – Time to Sell?

Biodexa Pharmaceuticals Plc (LON:MTPH) shares passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 18 ($0.24) and traded as low as GBX 12.50 ($0.17). Biodexa Pharmaceuticals shares last traded at GBX 18 ($0.24), with a volume of 73,672 shares trading hands.

Biodexa Pharmaceuticals Stock Up 1,794.7 %

The company has a current ratio of 5.28, a quick ratio of 5.28 and a debt-to-equity ratio of 9.52. The firm has a market cap of £31.20 million, a P/E ratio of -21.95 and a beta of 1.22. The company’s 50 day simple moving average is GBX 18 and its 200-day simple moving average is GBX 18.

Biodexa Pharmaceuticals Company Profile

Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection.